Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

In his new book, a former FDA commissioner unpacks the latest science on metabolism, weight loss, and how GLP-1 drugs ...

In a breakthrough for incretin medicines, China’s National Medical Products Administration (NMPA) has approved Innovent’s ...

One of America’s biggest household brands files for bankruptcy The long-awaited new Qantas plane touches down in soggy Sydney ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Instant ramen maker Nissin Foods is leveraging the buzz around GLP-1s to launch in the US a trio of decadent tasting frozen ...

There are two ways in which industry can respond to the GLP-1 craze. On the one hand, they can, like Nestlé, create smaller ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

Due to popularity of the medications, GLP-1s were in short supply up until recently. Obesity is a common issue among ...

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...